Application 216482
- Type
- NDA
- Sponsor
- AZURITY
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MYHIBBIN | MYCOPHENOLATE MOFETIL | SUSPENSION;ORAL | 200MG/ML | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N216482-001 | MYHIBBIN | MYCOPHENOLATE MOFETIL | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N216482-001 | 11931455 | 2039-08-16 | U-1752 | Drug product | 2024-05-15 |
| N216482-001 | 12097284 | 2039-08-16 | Drug product | 2024-09-27 | |
| N216482-001 | 12097285 | 2039-08-16 | U-1752 | Drug product | 2024-09-27 |
| N216482-001 | 12194143 | 2039-08-16 | U-1752 | Drug product | 2025-01-16 |
| N216482-001 | 12226526 | 2039-08-16 | U-1752 | Drug product | 2025-02-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | 1e350fbaab3a… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N216482-001 | MYHIBBIN | 200MG/ML | SUSPENSION / ORAL | RLD, RS | 2024-05-01 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N216482-001 | 11931455 | 2039-08-16 | U-1752 | Drug product | 2024-05-15 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216482-001 | 12097284 | 2039-08-16 | Drug product | 2024-09-27 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N216482-001 | 12097285 | 2039-08-16 | U-1752 | Drug product | 2024-09-27 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216482-001 | 12194143 | 2039-08-16 | U-1752 | Drug product | 2025-01-16 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N216482-001 | 12226526 | 2039-08-16 | U-1752 | Drug product | 2025-02-21 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N216482-001 | 11931455 | 2039-08-16 | U-1752 | Drug product | 2024-05-15 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N216482-001 | 12097284 | 2039-08-16 | Drug product | 2024-09-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N216482-001 | 12097285 | 2039-08-16 | U-1752 | Drug product | 2024-09-27 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N216482-001 | 12194143 | 2039-08-16 | U-1752 | Drug product | 2025-01-16 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N216482-001 | 12226526 | 2039-08-16 | U-1752 | Drug product | 2025-02-21 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N216482-001 | 11931455 | 2039-08-16 | U-1752 | Drug product | 2024-05-15 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N216482-001 | 12097284 | 2039-08-16 | Drug product | 2024-09-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N216482-001 | 12097285 | 2039-08-16 | U-1752 | Drug product | 2024-09-27 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N216482-001 | 12194143 | 2039-08-16 | U-1752 | Drug product | 2025-01-16 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N216482-001 | 12226526 | 2039-08-16 | U-1752 | Drug product | 2025-02-21 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N216482-001 | 11931455 | 2039-08-16 | U-1752 | Drug product | 2024-05-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216482-001 | 12097284 | 2039-08-16 | Drug product | 2024-09-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216482-001 | 12097285 | 2039-08-16 | U-1752 | Drug product | 2024-09-27 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216482-001 | 12194143 | 2039-08-16 | U-1752 | Drug product | 2025-01-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N216482-001 | 12226526 | 2039-08-16 | U-1752 | Drug product | 2025-02-21 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216482-001 | 11931455 | 2039-08-16 | U-1752 | Drug product | 2024-05-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216482-001 | 12097284 | 2039-08-16 | Drug product | 2024-09-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216482-001 | 12097285 | 2039-08-16 | U-1752 | Drug product | 2024-09-27 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216482-001 | 12194143 | 2039-08-16 | U-1752 | Drug product | 2025-01-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216482-001 | 12226526 | 2039-08-16 | U-1752 | Drug product | 2025-02-21 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N216482-001 | 11931455 | 2039-08-16 | U-1752 | Drug product | 2024-05-15 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N216482-001 | 12097284 | 2039-08-16 | Drug product | 2024-09-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216482-001 | 12097285 | 2039-08-16 | U-1752 | Drug product | 2024-09-27 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N216482-001 | 12194143 | 2039-08-16 | U-1752 | Drug product | 2025-01-16 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N216482-001 | 12226526 | 2039-08-16 | U-1752 | Drug product | 2025-02-21 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216482-001 | 11931455 | 2039-08-16 | U-1752 | Drug product | 2024-05-15 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216482-001 | 12097284 | 2039-08-16 | Drug product | 2024-09-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216482-001 | 12097285 | 2039-08-16 | U-1752 | Drug product | 2024-09-27 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216482-001 | 12194143 | 2039-08-16 | U-1752 | Drug product | 2025-01-16 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216482-001 | 12226526 | 2039-08-16 | U-1752 | Drug product | 2025-02-21 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216482-001 | 11931455 | 2039-08-16 | U-1752 | Drug product | 2024-05-15 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216482-001 | 12097284 | 2039-08-16 | Drug product | 2024-09-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216482-001 | 12097285 | 2039-08-16 | U-1752 | Drug product | 2024-09-27 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216482-001 | 12194143 | 2039-08-16 | U-1752 | Drug product | 2025-01-16 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216482-001 | 11931455 | 2039-08-16 | U-1752 | Drug product | 2024-05-15 | 03ed91905a0d… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MYCOPHENOLATE MOFETIL | MYCOPHENOLATE MOFETIL | Strides Pharma Science Limited | c1c4cb31-00a7-417e-9775-24e849d62791 | 2025-12-27 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| Mycophenolate mofetil | MYCOPHENOLATE MOFETIL | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 3ac54299-15cc-4c7a-8831-60c15a859b85 | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| MYCOPHENOLATE MOFETIL | MYCOPHENOLATE MOFETIL | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | df3ba2e9-00bb-40af-8658-2c5fd2e398ef | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| Mycophenolate mofetil | MYCOPHENOLATE MOFETIL | American Health Packaging | 8015f042-54fb-4a7a-a10b-6219e1a450c8 | 2025-12-08 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| Mycophenolate mofetil | MYCOPHENOLATE MOFETIL | Strides Pharma Science Limited | 32dd890a-cfe3-4129-bce6-1d3dbe38e4f3 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| Mycophenolate mofetil | MYCOPHENOLATE MOFETIL | Cardinal Health 107, LLC | f2eafcbb-77ab-461e-aa09-9cc4123eb3bd | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| Mycophenolate Mofetil | MYCOPHENOLATE MOFETIL | Wuxi Fortune Pharmaceutical Co.,Ltd. | ca633c6a-1e58-4faa-8e5d-71f89cefaa01 | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| mycophenolate mofetil | MYCOPHENOLATE MOFETIL | ONESOURCE SPECIALTY PHARMA LIMITED | 461a252f-ff81-4e08-b256-a497b14835fa | 2025-11-06 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| Mycophenolate Mofetil | MYCOPHENOLATE MOFETIL | Amneal Pharmaceuticals NY LLC | 5d7f7b88-79e3-4a56-a9f3-796c28049a60 | 2025-09-09 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| Mycophenolate mofetil | MYCOPHENOLATE MOFETIL | REMEDYREPACK INC. | afb59492-2bb1-4cf1-af4b-a5020b56c124 | 2025-09-08 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| MYCOPHENOLATE MOFETIL | MYCOPHENOLATE MOFETIL | Advagen Pharma Limited | a15c26d8-5a27-48ba-a669-8546803d901f | 2025-08-19 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| Mycophenolate Mofetil | MYCOPHENOLATE MOFETIL | Camber Pharmaceuticals, Inc. | 118e9bc8-c1a9-41d0-89e6-251f3be0b99c | 2025-08-02 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| MYCOPHENOLATE MOFETIL | MYCOPHENOLATE MOFETIL | CONCORD BIOTECH LIMITED | 64ac00ee-298c-49cf-a91c-78019a0d014d | 2025-07-25 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| Mycophenolate Mofetil | MYCOPHENOLATE MOFETIL | Sandoz Inc | 99b2eb58-8d14-48fc-bbe1-aacb711a783e | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| Mycophenolate Mofetil | MYCOPHENOLATE MOFETIL | Lannett Company, Inc. | 24c0b94a-c141-44b6-a6f0-ade1669b254c | 2025-07-17 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| Mycophenolate Mofetil | MYCOPHENOLATE MOFETIL | Mylan Institutional LLC | da02b428-42a4-4007-b0b7-695f2db010f2 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| Mycophenolate Mofetil | MYCOPHENOLATE MOFETIL | Hikma Pharmaceuticals USA Inc. | e94895d9-f040-4a75-9f04-9814238b8f3c | 2025-07-03 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| Mycophenolate mofetil | MYCOPHENOLATE MOFETIL | AvKARE | 339a10c4-e442-de9e-e063-6294a90a6208 | 2025-04-25 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| mycophenolate mofetil | MYCOPHENOLATE MOFETIL | ARMAS PHARMACEUTICALS INC | ffcc237c-f31b-77b8-e053-6294a90a603e | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
| mycophenolate mofetil | MYCOPHENOLATE MOFETIL | American Health Packaging | 75a76397-bb62-4014-8488-949a711b25f0 | 2025-03-04 | Boxed warning, Warnings, Adverse reactions | MYCOPHENOLATE MOFETIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.